GlobeNewswire: Chr. Hansen Holding A/S Contains the last 10 of 714 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T19:11:49ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/01/29/2818592/0/en/Completion-of-the-combination-between-Novozymes-and-Chr-Hansen.html?f=22&fvtc=4&fvtv=11200Completion of the combination between Novozymes and Chr. Hansen2024-01-29T10:27:01Z<![CDATA[January 29, 2024 – Company announcement no. 2]]>https://www.globenewswire.com/news-release/2024/01/26/2817778/0/en/All-necessary-regulatory-approvals-have-been-obtained-for-the-combination-of-Novozymes-and-Chr-Hansen.html?f=22&fvtc=4&fvtv=11200All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen2024-01-26T11:09:05Z<![CDATA[January 26, 2024 – Company announcement no. 1]]>https://www.globenewswire.com/news-release/2023/12/20/2799345/0/en/Update-on-the-merger-approval-process-for-the-combination-of-Novozymes-and-Chr-Hansen-South-Korean-merger-approval-granted.html?f=22&fvtc=4&fvtv=11200Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted2023-12-20T14:02:24Z<![CDATA[December 20, 2023]]>https://www.globenewswire.com/news-release/2023/12/19/2798361/0/en/Major-shareholder-announcement-from-Burlington-Loan-Management-DAC.html?f=22&fvtc=4&fvtv=11200Major shareholder announcement from Burlington Loan Management DAC2023-12-19T10:54:55Z<![CDATA[December 19, 2023 – Company announcement no. 12]]>https://www.globenewswire.com/news-release/2023/12/12/2794969/0/en/Update-on-the-merger-approval-process-for-the-combination-of-Novozymes-and-Chr-Hansen-Conditional-competition-clearance-from-the-European-Commission-obtained.html?f=22&fvtc=4&fvtv=11200Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained2023-12-12T16:11:39Z<![CDATA[December 12, 2023]]>https://www.globenewswire.com/news-release/2023/11/20/2782932/0/en/Update-on-the-merger-approval-process-for-the-combination-of-Novozymes-and-Chr-Hansen-The-parties-have-submitted-a-remedy-proposal-to-the-European-Commission.html?f=22&fvtc=4&fvtv=11200Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission.2023-11-20T07:03:35Z<![CDATA[November 20, 2023]]>https://www.globenewswire.com/news-release/2023/11/02/2772281/0/en/Managers-Transaction.html?f=22&fvtc=4&fvtv=11200Managers' Transaction2023-11-02T12:10:37Z<![CDATA[November 2, 2023 - Announcement No. 11]]>https://www.globenewswire.com/news-release/2023/10/13/2759978/0/en/Managers-Transactions.html?f=22&fvtc=4&fvtv=11200Managers' Transactions2023-10-13T13:16:01Z<![CDATA[October 13, 2023 - Announcement No. 10]]>https://www.globenewswire.com/news-release/2023/10/12/2758941/0/en/Chr-Hansen-Holding-A-S-Interim-Report-Q4-2022-23.html?f=22&fvtc=4&fvtv=11200Chr. Hansen Holding A/S Interim Report Q4 2022/232023-10-12T06:02:19Z<![CDATA[October 12, 2023 – Company announcement no. 9]]>https://www.globenewswire.com/news-release/2023/10/10/2757136/0/en/Novozymes-announce-the-Executive-Leadership-Team-and-organizational-structure-for-the-future-combined-company-of-Novozymes-and-Chr-Hansen.html?f=22&fvtc=4&fvtv=11200Novozymes announce the Executive Leadership Team and organizational structure for the future combined company of Novozymes and Chr. Hansen2023-10-10T06:08:19Z<![CDATA[October 10, 2023]]>